injewelme Co., Ltd.

injewelme Co. , Ltd. , based in South Korea, specializes in innovative AI and data technology solutions that enhance personal health and lifestyle management, targeting preventive healthcare for children and vulnerable populations. Founded in 2020 in Seoul, South Korea, injewelme Co.

, Ltd. focuses on developing digital healthcare solutions. The company has completed 3 deals, with the most recent funding round occurring on February 1, 2022, through the Angel funding stage, involving investment from Korea Tech Incubator for Startup. The founder's information is currently unavailable.

injewelme delivers innovative products centered around artificial intelligence and data technology to enhance personal health and lifestyle management. Their core offerings include AI-based solutions for preventive healthcare, specifically targeting children and adolescents, as well as services for socially vulnerable groups. Their flagship applications, branded as WUD! for Obesity Care and WUD!

for Mind Care, utilize gamification techniques to engage users, promoting adherence to health management routines through enjoyable interactions. The company primarily targets markets in South Korea and the Asia Pacific region, empowering individuals to leverage personal data tailored to their unique circumstances. injewelme's revenue model is subscription-based, allowing clients, including healthcare institutions and individual consumers, to engage regularly with their digital healthcare solutions. The operations include direct-to-consumer sales where users subscribe for ongoing access to services such as WUD!

for Obesity Care and WUD! for Mind Care, each featuring specific pricing plans that reflect the personalized data and technology offered. Strategic partnerships within the healthcare ecosystem further enhance revenue potential by broadening service reach and operational capacity. As of now, injewelme is focused on expanding its product offerings and market presence.

The company aims to develop new products and enhance existing applications, with specific launch dates yet to be announced. They are targeting expansion into new geographic regions in the Asia Pacific by the end of 2023. The recent Angel funding round will support these initiatives, enabling injewelme to strengthen its operational capacity and further its development in digital healthcare solutions.